Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
Clinical trial NCT05245669 · COMPLETED
Trial details
- NCT number
- NCT05245669
- Sponsor
- Enzene Biosciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2024-05-22
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.